Latest news articles

Added 1 year ago Drug news

FDA approves Kedrab [rabies immune globulin (Human)]for passive, transient post-exposure prophylaxis of rabies infection.- Kedrion Biopharma + Kamada Ltd.

Kedrion Biopharma and Kamada Ltd. two leading human-derived protein therapeutics companies, announced that Kedrab [rabies immune globulin (Human)] has received...

Added 2 years ago Drug news

FDA accepts for review a human anti-rabies immunoglobulin (IgG) therapy to treat rabies.- Kedrion Biopharma + Kamada Ltd

Kedrion Biopharma, and Kamada Ltd., two leading human-derived protein therapeutics companies, have announced that the FDA has accepted for review...

Search all news articles for Immunisations and screening

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more


The Prevention of Early-onset Neonatal Group B Streptococcal Disease

The purpose of this guideline is to provide guidance for obstetricians, midwives and neonatologists on the prevention of early-onset (less than 7 days of age) neonatal group B streptococcal (EOGBS) disease...

Added 6 years ago

Suspected cancer: recognition and referral

This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion.

Added 3 years ago

Chickenpox in Pregnancy

Varicella, the primary infection with varicella-zoster virus (VZV; human herpesvirus 3), in pregnancy may cause maternal mortality or serious morbidity. It may also cause fetal varicella syndrome (FVS) and varicella infection of the newborn...

Added 3 years ago

Search all guidelines for Immunisations and screening

Journal articles

Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).

Neisseria meningitidis is a common cause of bacterial meningitis, often leading to permanent sequelae or death. N. meningitidis is classified into serogroups based on the composition of the bacterial capsular polysaccharide...

Added 9 months ago

The Dual Role of Lipids of the Lipoproteins in Trumenba, a Self-Adjuvanting Vaccine Against Meningococcal Meningitis B Disease.

Trumenba (bivalent rLP2086) is a vaccine licensed for the prevention of meningococcal meningitis disease caused by Neisseria meningitidis serogroup B (NmB) in individuals 10-25 years of age in the USA.

Added 9 months ago

Adverse Events Following Vaccination With Bivalent rLP2086 (Trumenba®): An Observational, Longitudinal Study During a College Outbreak and a Systematic Review.

Background: In February 2015, two unlinked culture-confirmed cases of Neisseria meningitidis serogroup B (MenB) disease occurred at a local college in Rhode Island ("college X") within 3 days.

Added 9 months ago

Search all journal articles for Immunisations and screening